chemical structure of tirzepatide (LY3298176) sodium | GIP/GLP-1 Receptor Agonist | CAS 2023788-19-2 (free base) Tirzepatide (5-39) CAS#: N/A •

From a metabolic perspective, slower gastric emptying contributes to improved postprandial glucose control by moderating the rate at which carbohydrates enter the circulation, thereby reducing glucose excursions after meals

Understanding Diabetes Risk in COPD Patients Individuals with COPD experience higher rates of type 2 diabetes due to shared inflammatory pathways, corticosteroid use, and reduced physical activity levels

Age, weight, and comorbid conditions impact pharmaceutical pharmacokinetics, glycemic management, and operative risk

It also slows gastric emptying, meaning food stays in the stomach longer, supporting the sensation of fullness